2022 Q4 Form 10-Q Financial Statement
#000147793222009330 Filed on December 15, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q2 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $18.15K | $15.06K |
YoY Change | -16.17% | 1058.46% |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $18.15K | $15.06K |
YoY Change | -16.17% | 1058.46% |
Operating Profit | -$18.15K | -$427.7K |
YoY Change | -16.14% | |
Interest Expense | $2.776K | |
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | $2.776K | |
YoY Change | ||
Pretax Income | -$18.15K | -$15.06K |
YoY Change | -16.17% | 1058.46% |
Income Tax | $0.00 | |
% Of Pretax Income | ||
Net Earnings | -$18.15K | -$15.06K |
YoY Change | -16.14% | 1058.46% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$2.375K | -$1.971K |
COMMON SHARES | ||
Basic Shares Outstanding | 7.642M shares | 7.642M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q4 | 2022 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $5.024K | $5.160K |
YoY Change | 176.04% | 1417.65% |
Cash & Equivalents | $4.924K | $5.161K |
Short-Term Investments | $100.00 | $100.00 |
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | $0.00 | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $4.924K | $5.161K |
YoY Change | 171.0% | 1409.06% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $100.00 | $100.00 |
YoY Change | 0.0% | 0.0% |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $100.00 | $100.00 |
YoY Change | 0.0% | 0.0% |
TOTAL ASSETS | ||
Total Short-Term Assets | $4.924K | $5.161K |
Total Long-Term Assets | $100.00 | $100.00 |
Total Assets | $5.024K | $5.261K |
YoY Change | 162.08% | 1090.27% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $28.40K | $30.91K |
YoY Change | 11.59% | 7.89% |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $179.2K | $153.2K |
YoY Change | 42.0% | 65.81% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | $0.00 |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $179.2K | $153.2K |
Total Long-Term Liabilities | $0.00 | $0.00 |
Total Liabilities | $179.2K | $153.2K |
YoY Change | 42.0% | 65.81% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$5.173M | -$5.147M |
YoY Change | 0.97% | 1.1% |
Common Stock | $764.00 | $764.00 |
YoY Change | 0.0% | 0.0% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | $52.95K | $52.95K |
YoY Change | 0.0% | 0.0% |
Treasury Stock Shares | 1.000 shares | 1.000 shares |
Shareholders Equity | -$174.2K | -$148.0K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $5.024K | $5.261K |
YoY Change | 162.08% | 1090.27% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$18.15K | -$15.06K |
YoY Change | -16.14% | 1058.46% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$27.05K | -$14.09K |
YoY Change | 11.09% | 570.95% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 28.50K | 14.00K |
YoY Change | 375.0% | |
NET CHANGE | ||
Cash From Operating Activities | -27.05K | -14.09K |
Cash From Investing Activities | ||
Cash From Financing Activities | 28.50K | 14.00K |
Net Change In Cash | 1.450K | -90.00 |
YoY Change | -107.9% | -95.71% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$27.05K | -$14.09K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001134982 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--04-30 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7642211 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7642210 | shares |
CY2022Q2 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
1 | shares |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-10-31 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-32389 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
PREVENTION INSURANCE.COM | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
88-0126444 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
First Floor, Prohasky Street | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Port Melbourne | ||
dei |
Entity Address Country
EntityAddressCountry
|
AU | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
3207 | ||
dei |
City Area Code
CityAreaCode
|
61 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
8 8981 4037 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7642210 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7642211 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7642210 | shares |
CY2022Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
1 | shares |
CY2022Q4 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2021Q4 | us-gaap |
Revenues
Revenues
|
0 | usd |
us-gaap |
Revenues
Revenues
|
0 | usd | |
us-gaap |
Revenues
Revenues
|
0 | usd | |
CY2022Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
18152 | usd |
CY2021Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21646 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
26222 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
32325 | usd | |
CY2022Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18152 | usd |
CY2021Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-21646 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-26222 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-32325 | usd | |
CY2022Q4 | us-gaap |
Profit Loss
ProfitLoss
|
-18152 | usd |
CY2021Q4 | us-gaap |
Profit Loss
ProfitLoss
|
-21646 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-26222 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-32325 | usd | |
CY2022Q4 | pvnc |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
7642210 | shares |
CY2021Q4 | pvnc |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
7642210 | shares |
pvnc |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
7642210 | shares | |
pvnc |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
7642210 | shares | |
CY2022Q4 | pvnc |
Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
|
-0.00 | |
CY2021Q4 | pvnc |
Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
|
-0.00 | |
pvnc |
Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
|
-0.00 | ||
pvnc |
Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
|
-0.00 | ||
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-91960 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10679 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102639 | usd |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-21644 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-124285 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-147955 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8070 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-156025 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18152 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-174177 | usd |
pvnc |
Net Income Losses
NetIncomeLosses
|
26222 | usd | |
pvnc |
Net Income Losses
NetIncomeLosses
|
32325 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-2515 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3200 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-28737 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-35525 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
28500 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
37000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
28500 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
37000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-237 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
1475 | usd | |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5161 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
342 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4924 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1817 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q1 | pvnc |
Description Of Corporate Actions
DescriptionOfCorporateActions
|
The record date of the Corporate Actions was March 1, 2022, whereby our majority stockholder, holding 85% of our outstanding voting securities, executed written consent approving Corporate Actions. | |
us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The summary of significant accounting policies is presented to assist in the understanding of the financial statements. These policies conform to accounting principles generally accepted in the United States of America (“GAAP”) and have been consistently applied.</p> | ||
pvnc |
Interim Financial Statementspolicytextblock
InterimFinancialStatementspolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of October 31, 2022 and for the related periods presented, have been included. The results for the three and six months period ended October 31, 2022 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended April 30, 2022 and 2021 included in our Form 10-K filed on September 16, 2022.</p> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> | ||
CY2022Q4 | pvnc |
Cash Balance
CashBalance
|
4924 | usd |
CY2022Q2 | pvnc |
Cash Balance
CashBalance
|
5161 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-26222 | usd | |
CY2022Q4 | pvnc |
Retained Earnings And Accumulated Deficit
RetainedEarningsAndAccumulatedDeficit
|
-5172756 | usd |
us-gaap |
Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
|
0.10 | pure | |
pvnc |
Covid19 Uncertaintiespolicy Textblock
Covid19UncertaintiespolicyTextblock
|
<p style="font-size:10pt;font-family:times new roman;margin:0px">The COVID-19 pandemic could have an impact on our ability to obtain financing to fund the operations. The Company is unable to predict the ultimate impact at this time.</p> | ||
CY2022Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
122302 | usd |
CY2022Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
150802 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7642211 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7642210 | shares |
CY2022Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
52954 | usd |